Cassidy Blundell

Cassidy Blundell, PhD is a Principal based in the Cambridge office. She is responsible for sourcing and assessing new investment opportunities as part of the diligence team as well as assisting in management of the portfolio. She holds a board role at ARase Therapeutics. Before joining the firm as an analyst in 2018, Cassidy completed her graduate studies at the University of Pennsylvania in the HHMI Interfaces program. Cassidy’s doctorate research focused on development of microengineered in vitro systems to study the human placenta, which were used to investigate maternal-fetal transport and placental development. Cassidy holds a PhD in Bioengineering from the University of Pennsylvania and a B.S. in Biomedical Engineering from Boston University.